Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-T) Enrolled in a Phase 3 Study of CPX-351 Versus Conventional 7?+?3 Cytarabine and Daunorubicin

著录项

• 来源
  《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共2页
• 作者

  Tara L. Lin; Geoffrey L. Uy; Matthew J. Wieduwilt; Laura F. Newell; Robert K. Stuart; Bruno C. Medeiros; Gary J. Schiller; S. Eric Rubenstein; Wendy Stock; Erica Warlick; Matthew Foster; Dale L. Bixby; Nikolai Podoltsev; Qi An; Stefan Faderl; Arthur C. Louie; Jeffrey E. Lancet;

  展开▼
• 作者单位

  University of Kansas Medical Center;

  Washington University School of Medicine;

  University of California—San Diego Moores Cancer Center;

  Center for Hematologic Malignancies Knight Cancer Institute Oregon Health &

  Science University;

  Hollings Cancer Center Medical University of South Carolina;

  Stanford University School of Medicine;

  Medicine Hematology-Oncology David Geffen School of Medicine at UCLA;

  Franciscan Health;

  University of Chicago;

  University of Minnesota;

  University of North Carolina Lineberger Cancer Center;

  Comprehensive Cancer Center University of Michigan;

  Yale University School of Medicine;

  Jazz Pharmaceuticals;

  Jazz Pharmaceuticals;

  Jazz Pharmaceuticals;

  H. Lee Moffitt Cancer Center &

  Research Institute;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 治疗学;
• 关键词